## OWEN MUIR

| | Title| Clinical Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Psychiatry & Behavioral Sciences  
Address| One Baylor Plaza  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=ZPhgsDCXQIn2S8Ho5G4%3d&rnd=13e93aa1-4054-4903-9079-107769149836)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=30445251)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Beutler BD, Shinozuka K, Tabaac BJ, Arenas A, Cherian K, Evans VD, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Am J Ther. 2024 Mar-Apr 01; 31(2):e104-e111. PMID: [38518267](//www.ncbi.nlm.nih.gov/pubmed/38518267).

Citations:  Fields:

The Therapeutics

Translation:Humans

  2. Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca. Am J Ther. 2024 Mar-Apr 01; 31(2):e112-e120. PMID: [38518268](//www.ncbi.nlm.nih.gov/pubmed/38518268).

Citations:  Fields:

The Therapeutics

Translation:HumansAnimals

  3. Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA). Am J Ther. 2024 Mar-Apr 01; 31(2):e141-e154. PMID: [38518271](//www.ncbi.nlm.nih.gov/pubmed/38518271).

Citations:  Fields:

The Therapeutics

Translation:HumansAnimals

  4. Cherian K, Shinozuka K, Tabaac BJ, Arenas A, Beutler BD, Evans VD, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine. Am J Ther. 2024 Mar-Apr 01; 31(2):e133-e140. PMID: [38518270](//www.ncbi.nlm.nih.gov/pubmed/38518270).

Citations:  Fields:

The Therapeutics

Translation:Humans

  5. **Muir OS** , Shinozuka K, Beutler BD, Arenas A, Cherian K, Evans VD, Fasano C, Tabaac BJ. Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics. Am J Ther. 2024 Mar-Apr 01; 31(2):e178-e182. PMID: [38518273](//www.ncbi.nlm.nih.gov/pubmed/38518273).

Citations:  Fields:

The Therapeutics

Translation:Humans

  6. Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin. Am J Ther. 2024 Mar-Apr 01; 31(2):e121-e132. PMID: [38518269](//www.ncbi.nlm.nih.gov/pubmed/38518269).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38518269/citedby/) Fields:

The Therapeutics

Translation:Humans

  7. Evans VD, Arenas A, Shinozuka K, Tabaac BJ, Beutler BD, Cherian K, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine. Am J Ther. 2024 Mar-Apr 01; 31(2):e155-e177. PMID: [38518272](//www.ncbi.nlm.nih.gov/pubmed/38518272).

Citations:  Fields:

The Therapeutics

Translation:Humans

  8. Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, **Muir OS**. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview. Am J Ther. 2024 Mar-Apr 01; 31(2):e97-e103. PMID: [38518266](//www.ncbi.nlm.nih.gov/pubmed/38518266).

Citations:  Fields:

The Therapeutics

Translation:Humans

  9. Solomon TM, Hajduk M, Majernik M, Jemison J, Deschamps A, Scoggins J, Kolar A, Pinheiro MA, Dubec P, Skala O, **Muir O** , Tinkelman A, Karlin DR, Barrow R. Evaluating passive physiological data collection during Spravato treatment. Front Digit Health. 2023; 5:1281529. PMID: [38094111](//www.ncbi.nlm.nih.gov/pubmed/38094111); PMCID: [PMC10716422](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10716422).

Citations:

  10. Roth Y, Hanlon CA, Pell G, Zibman S, Harmelech T, **Muir OS** , MacMillan C, Prestley T, Purselle DC, Knightly T, Tendler A. Real world efficacy and safety of various accelerated deep TMS protocols for major depression. Psychiatry Res. 2023 Oct; 328:115482. PMID: [37738684](//www.ncbi.nlm.nih.gov/pubmed/37738684).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37738684/citedby/) Fields:

Psy Psychiatry

  11. Tendler A, Goerigk S, Zibman S, Ouaknine S, Harmelech T, Pell GS, Zangen A, Harvey SA, Grammer G, Stehberg J, Adefolarin O, **Muir O** , MacMillan C, Ghelber D, Duffy W, Mania I, Faruqui Z, Munasifi F, Antin T, Padberg F, Roth Y. Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis. Psychiatry Res. 2023 06; 324:115179. PMID: [37030054](//www.ncbi.nlm.nih.gov/pubmed/37030054).

Citations:  Fields:

Psy Psychiatry

Translation:HumansCTClinical Trials

  12. Harmelech T, Tendler A, Vidrine R, **Muir O** , MacMillan C, Sinclair R, Shakir S, Kent D, Evangelidis N, Roth Y, Arikan MK, ?etin HL, Esmeray MT, Ilhan R. Long-term outcomes of a course of deep TMS for treatment-resistant OCD. Brain Stimul. 2022 Jan-Feb; 15(1):226-228. PMID: [34982981](//www.ncbi.nlm.nih.gov/pubmed/34982981).

Citations:  Fields:

Bra Brain

Translation:Humans

  13. **Muir O** , Weinfeld JN, Ruiz D, Ostrovsky D, Fiolhais M, MacMillan C. Mental health clinicians' attitudes toward narcissistic personality disorder. Personal Disord. 2021 09; 12(5):389-399. PMID: [34793187](//www.ncbi.nlm.nih.gov/pubmed/34793187).

Citations:  Fields:

Psy Psychology

Translation:Humans

  14. Roth Y, Tendler A, Vidrine R, Kent D, **Muir O** , MacMillan C, Casuto L, Grammer G, Sauve W, Tolin K, Harvey S, Borst M, Rifkin R, Sheth M, Cornejo B, Rodriguez R, Shakir S, Porter T, Kim D, Peterson B, Swofford J, Roe B, Sinclair R, Harmelech T, Zangen A, Arikan MK. Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites. J Psychiatr Res. 2021 05; 137:667-672. PMID: [33183769](//www.ncbi.nlm.nih.gov/pubmed/33183769).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33183769/citedby/) Fields:

Psy Psychiatry

Translation:Humans

  15. Peek HS, Richards M, **Muir O** , Chan SR, Caton M, MacMillan C. Blogging and Social Media for Mental Health Education and Advocacy: a Review for Psychiatrists. Curr Psychiatry Rep. 2015 Nov; 17(11):88. PMID: [26377948](//www.ncbi.nlm.nih.gov/pubmed/26377948).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26377948/citedby/) Fields:

Psy Psychiatry

Translation:Humans

  16. Manu P, Sarpal D, **Muir O** , Kane JM, Correll CU. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res. 2012 Feb; 134(2-3):180-6. PMID: [22113154](//www.ncbi.nlm.nih.gov/pubmed/22113154); PMCID: [PMC3318984](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3318984).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22113154/citedby/) Fields:

Psy Psychiatry

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 16 publications over 7 distinct years, with a maximum of 8
publications in
2024](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|8&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13,0,0,0,13,0,0,0,0,13,13,13,38,100&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2011| 1  
2015| 1  
2020| 1  
2021| 1  
2022| 1  
2023| 3  
2024| 8  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

MUIR's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (61)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Hallucinogens](https://profiles.viictr.org/profile/255371)
  * [Depressive Disorder, Major](https://profiles.viictr.org/profile/252033)
  * [Primary Health Care](https://profiles.viictr.org/profile/242824)
  * [N-Methyl-3,4-methylenedioxyamphetamine](https://profiles.viictr.org/profile/241253)
  * [Banisteriopsis](https://profiles.viictr.org/profile/256012)

[Explore](https://profiles.viictr.org/profile/30445251/198)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [MATHEW, SANJAY](https://profiles.viictr.org/profile/269727)
  * [ABDALLAH, CHADI](https://profiles.viictr.org/profile/30909013)
  * [STORCH, ERIC](https://profiles.viictr.org/profile/23478906)
  * [MCGUIRE, AMY](https://profiles.viictr.org/profile/269988)
  * [KOSTEN, THOMAS](https://profiles.viictr.org/profile/265715)

[Explore](https://profiles.viictr.org/profile/30445251/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [GRANT, PATRICK](https://profiles.viictr.org/profile/41234759)
  * [NESS, DAVID](https://profiles.viictr.org/profile/266357)
  * [RIAHI, COLETTE](https://profiles.viictr.org/profile/19013067)
  * [SHARP, CARLA](https://profiles.viictr.org/profile/270256)
  * [SIFFERT, VERONICA](https://profiles.viictr.org/profile/22166779)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

